📰 Bone Biologic News
Bone Biologic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bone Biologic. Real-time updates on events, politics, business and more.
May 18, 2024
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Bone Biologics (NASDAQ:BBLG – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent […]
April 9, 2024
STERIS (NYSE:STE – Get Free Report) and Bone Biologics (NASDAQ:BBLG – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Insider & Institutional Ownership 94.7% of STERIS shares are […]
April 9, 2024
Avanos Medical (NYSE:AVNS – Get Free Report) and Bone Biologics (NASDAQ:BBLG – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Risk & Volatility Avanos Medical has a […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 48 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it contrast to its competitors? We will compare Bone Biologics to similar companies based on the strength of its dividends, institutional ownership, analyst recommendations, profitability, earnings, valuation and risk. Insider and Institutional […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its competitors? We will compare Bone Biologics to related companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations. Volatility […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its peers? We will compare Bone Biologics to similar businesses based on the strength of its analyst recommendations, valuation, risk, institutional ownership, dividends, earnings and profitability. Insider & Institutional […]
January 18, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 50 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Bone Biologics to related businesses based on the strength of its earnings, profitability, valuation, analyst recommendations, dividends, institutional ownership and risk. Volatility […]
January 17, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Bone Biologics to similar companies based on the strength of its profitability, dividends, earnings, valuation, analyst recommendations, risk and institutional ownership. Volatility and Risk […]
January 10, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 49 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Bone Biologics to related companies based on the strength of its analyst recommendations, earnings, risk, institutional ownership, profitability, dividends and valuation. Earnings […]
January 8, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 49 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its peers? We will compare Bone Biologics to related businesses based on the strength of its valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Valuation […]